[FDG-PET/CT in oncology. German Guideline].
FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.
Krause
B J
BJ
Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität, Ismaninger Strasse 22, 81675 Munich. bernd-joachim.krause@tum.de
Beyer
T
T
Bockisch
A
A
Delbeke
D
D
Kotzerke
J
J
Minkov
V
V
Reiser
M
M
Willich
N
N
D004282:Documentation; D019788:Fluorodeoxyglucose F18; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000592:standards*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000592:standards*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18